Because Expertise Matters
Join Cyberounds®, an online education community for health professionals Sign Up

Log In

The Medical Treatment of Lipid Disorders

Go directly to drug therapy without first testing the diet response if the patient has established heart disease.
CME credit is no longer available for this conference.

Course Authors

Ernst John Schaefer, M.D., and Robert M. Russell, M.D.

Ernst John Schaefer is professor of medicine at Tufts University School of Medicine, Director of the Heart Disease Prevention Program at New England Medical Center, and senior scientist and Chief, Lipid Metabolism Laboratory of the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University. He graduated from Harvard College, Dartmouth Medical School and Mt. Sinai School of Medicine, trained in internal medicine at Mt. Sinai and in endocrinology and lipoprotein research at the National Institutes of Health. Dr. Schaefer served on the first and second Adult Treatment Panels of the National Cholesterol Education Program which generated U.S. guidelines for cholesterol management. He is the U.S. editor of the journal Atherosclerosis. His research focuses on the nutritional and genetic regulation of plasma lipoproteins. Dr. Schaefer reports no commercial conflict of interest. In the last three years, Dr. Russell has received grant/research support from BASF and Roche Vitamins. Dr. Russell has also served as a consultant for Whitehall Robbins-Quaker.

Release Date: 06/30/1998

 
Learning Objectives

Upon completion of this Cyberounds®, you should be able to:

  • Classify lipid disorders by the use of individual laboratory values for LDL cholesterol, HDL cholesterol and triglyceride

  • Identify which drugs are used for which lipid disorders

  • Identify the secondary causes of hypercholesterolemia.

 

TERMS AND CONDITIONS

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms.

Courses You Might Like

Low Carb v. High Protein Diets: 2019 Update

Approximately two-thirds of Americans are now classified as overweight or obese. Genetic predisposition to a hunter-gatherer or farmer-based metabolism may play a role.
Authors: Edward Saltzman, M.D., is Academic Dean for Education at the Friedman School of Nutrition Science and Policy, Associate Professor at the School of Medicine, and scientist at the Energy Metabolism Laboratory in the Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA.
More

Vitamin D in Health and Disease

Vitamin D has received increasing attention over the past decades for its potential role in cardiovascular disease, pregnancy, infection and malignancy, among other diseases.
Authors: Malcolm D. Kearns, M.D., and Vin Tangpricha, M.D., Ph.D.
More

Genetically Modified Foods: Scientific Perspective and Controversies

For more than a decade Golden Rice has had a pivotal role in the arguments for and against genetic engineering.
Authors: Adrian Dubock, Ph.D.
More

Sports Nutrition for an Adult Female Endurance Athlete

Active adults and athletes can improve their physical performance by making appropriate food and fluid intake choices.
Authors: Lona Sandon, M.Ed., R.D.
More

Current Management of Obesity

Sixty−six percent of Americans are either overweight or obese.
Authors: Lawrence J. Cheskin, M.D., and Scott Kahan, M.D., M.P.H.
More

Selenium: A Trace Element with Abundant Potential

Selenium is an essential micronutrient with several important physiologic roles in the human body.
Authors: Mark Sutter, M.D., and Jennifer Brown, M.D.
More